BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9792554)

  • 1. Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-gamma2 gene with obesity in two Caucasian populations.
    Beamer BA; Yen CJ; Andersen RE; Muller D; Elahi D; Cheskin LJ; Andres R; Roth J; Shuldiner AR
    Diabetes; 1998 Nov; 47(11):1806-8. PubMed ID: 9792554
    [No Abstract]   [Full Text] [Related]  

  • 2. [Association of Pro12Ala variant in peroxisome proliferator-activated receptor-gamma2 gene with type 2 diabetes mellitus].
    Fu M; Chen H; Li X; Li J; Wu B; Cheng L; Cai M; Fu Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):234-8. PubMed ID: 12048686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the Pro12Ala polymorphism in the peroxisome proliferator-activated receptor (PPAR) gamma2 gene on the expression of PPARgamma target genes in adipose tissue of massively obese subjects.
    Kolehmainen M; Uusitupa MI; Alhava E; Laakso M; Vidal H
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1717-22. PubMed ID: 12679463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients.
    Auboeuf D; Rieusset J; Fajas L; Vallier P; Frering V; Riou JP; Staels B; Auwerx J; Laville M; Vidal H
    Diabetes; 1997 Aug; 46(8):1319-27. PubMed ID: 9231657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Missense variants in the human peroxisome proliferator-activated receptor-gamma2 gene in lean and obese subjects.
    Hamann A; Münzberg H; Buttron P; Büsing B; Hinney A; Mayer H; Siegfried W; Hebebrand J; Greten H
    Eur J Endocrinol; 1999 Jul; 141(1):90-2. PubMed ID: 10407229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nutrient channelling-regulated peroxisome proliferator-activated receptor-gamma-2 (PPARgamma-2) and leptin gene expression in human subcutaneous fat.
    Nisoli E; Vettor R; Tonello C; Macor C; Federspil G; Carruba MO
    Diabetologia; 1999 Apr; 42(4):495-7. PubMed ID: 10230656
    [No Abstract]   [Full Text] [Related]  

  • 7. [Association of Pro12Ala mutation in peroxisome proliferator-activated receptor gamma 2 with obesity and diabetes in Chinese population].
    Wang C; Zhai F; Chi Y; Wang G
    Wei Sheng Yan Jiu; 2004 May; 33(3):317-20. PubMed ID: 15211802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 (PPARgamma2) is associated with higher levels of total cholesterol and LDL-cholesterol in male caucasian type 2 diabetes patients.
    Zietz B; Barth N; Spiegel D; Schmitz G; Schölmerich J; Schäffler A
    Exp Clin Endocrinol Diabetes; 2002 Apr; 110(2):60-6. PubMed ID: 11928067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the peroxisome proliferator activated receptor-gamma gene Pro12Ala variant on body mass index: a meta-analysis.
    Masud S; Ye S;
    J Med Genet; 2003 Oct; 40(10):773-80. PubMed ID: 14569127
    [No Abstract]   [Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids.
    Vidal-Puig AJ; Considine RV; Jimenez-Liñan M; Werman A; Pories WJ; Caro JF; Flier JS
    J Clin Invest; 1997 May; 99(10):2416-22. PubMed ID: 9153284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation.
    Yen CJ; Beamer BA; Negri C; Silver K; Brown KA; Yarnall DP; Burns DK; Roth J; Shuldiner AR
    Biochem Biophys Res Commun; 1997 Dec; 241(2):270-4. PubMed ID: 9425261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of PPAR gamma gene expression by nutrition and obesity in rodents.
    Vidal-Puig A; Jimenez-Liñan M; Lowell BB; Hamann A; Hu E; Spiegelman B; Flier JS; Moller DE
    J Clin Invest; 1996 Jun; 97(11):2553-61. PubMed ID: 8647948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes.
    Mancini FP; Vaccaro O; Sabatino L; Tufano A; Rivellese AA; Riccardi G; Colantuoni V
    Diabetes; 1999 Jul; 48(7):1466-8. PubMed ID: 10389855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homozygosity of the Pro12Ala variant of the peroxisome proliferation-activated receptor-gamma2 (PPAR-gamma2): divergent modulating effects on body mass index in obese and lean Caucasian men.
    Ek J; Urhammer SA; Sørensen TI; Andersen T; Auwerx J; Pedersen O
    Diabetologia; 1999 Jul; 42(7):892-5. PubMed ID: 10440134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency and significance of Pro12Ala and Pro115Gln polymorphism in gene for peroxisome proliferation-activated receptor-gamma regarding metabolic parameters in a Caucasian cohort.
    Schäffler A; Barth N; Schmitz G; Zietz B; Palitzsch KD; Schölmerich J
    Endocrine; 2001 Apr; 14(3):369-73. PubMed ID: 11444435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipose peroxisome proliferator-activated receptor gamma mRNA expression in insulin-resistant obese patients: relationship with adipocyte membrane phospholipids.
    Zeghari N; Vidal H; Perche S; Meyer L; Ziegler O; Guerci B; Donner M; Drouin P
    Lipids; 1999; 34 Suppl():S161. PubMed ID: 10419134
    [No Abstract]   [Full Text] [Related]  

  • 17. Association of the PRO12ALA polymorphism of the PPAR-gamma2 gene with oxidized low-density lipoprotein and cardiolipin autoantibodies in nondiabetic and type 2 diabetic subjects.
    Niskanen L; Lindi V; Erkkilä A; Sivenius K; Luoma J; Ylä-Herttuala S; Laakso M; Uusitupa MI
    Metabolism; 2003 Feb; 52(2):213-7. PubMed ID: 12601635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism.
    Stumvoll M; Häring H
    Diabetes; 2002 Aug; 51(8):2341-7. PubMed ID: 12145143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The peroxisome proliferator-activated receptor-gamma2 Pro12A1a variant: association with type 2 diabetes and trait differences.
    Douglas JA; Erdos MR; Watanabe RM; Braun A; Johnston CL; Oeth P; Mohlke KL; Valle TT; Ehnholm C; Buchanan TA; Bergman RN; Collins FS; Boehnke M; Tuomilehto J
    Diabetes; 2001 Apr; 50(4):886-90. PubMed ID: 11289057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Pro12Ala variant of peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) is associated with measures of obesity in Mexican Americans.
    Cole SA; Mitchell BD; Hsueh WC; Pineda P; Beamer BA; Shuldiner AR; Comuzzie AG; Blangero J; Hixson JE
    Int J Obes Relat Metab Disord; 2000 Apr; 24(4):522-4. PubMed ID: 10805513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.